Crescita Therapeutics Secures Court Approval for Arrangement with ClinActiv

Crescita Therapeutics Inc., a company listed on the Toronto Stock Exchange (TSX: CTX) and over-the-counter in the United States (OTC US: CRRTF), announced that it has received a final order from the Ontario Superior Court of Justice (Commercial List). The court approved the company's previously announced plan of arrangement with ClinActiv Holdings Inc. and ClinActiv’s wholly‑owned subsidiary.

The approval allows Crescita to move forward with the restructuring outlined in the arrangement, which was intended to address corporate and financial objectives for both parties.